Torrent Pharmaceuticals Ltd
₹4,447
▼-0.39%
Open
₹4,489.35
High
₹4,490.05
Low
₹4,415.8
Volume
324.2K
Price chart
Daily close · downsampled 5-year history
2021-06-21 · ₹1,459.252026-06-18 · ₹4,437.15
Instrument details
- MB Code
- MBEQU1380
- Type
- stock
- ISIN
- INE685A01028
- BSE
- 500420
- Industry
- Pharmaceuticals & Biotechnology
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 4197 Cr
- Net profit
- 364 Cr
- EPS
- 11.51
- YoY revenue
- +41.84%
Price returns
Historical performance
- 1 day
- -0.25%
- 1 month
- -0.45%
- 3 months
- +3.97%
- 1 year
- +37.52%
- 3 years
- +138.82%
- 5 years
- +206.18%
Technicals
Indicator consensus
Bullish
19
Neutral
9
Bearish
18
RSI 50.28(Neutral)
Company documents
Annual reports, concalls, presentations
Concall transcripts
60Investor presentations
20Corporate announcements
307Corporate timeline
Price chart events · 1 year
Dividend
2025-06-20
{"amount":6}
Dividend
2026-02-18
{"amount":29}
Dividend
2026-05-29
{"amount":9}
Earnings
2026-02-13
{"actualRevenue":33030000000,"estimateRevenue":33291000000,"revenueSurprise":-261000000,"revenueSurprisePercent":-0.7839956745066234,"actualEPS":19.07,"estimateEPS":18.8325966,"surprise":0.2374034000000016,"surprisePercent":1.260598339370799}
Earnings
2026-05-22
{"actualRevenue":41970000000,"estimateRevenue":40965000000,"revenueSurprise":1005000000,"revenueSurprisePercent":2.453313804467228,"actualEPS":13.46,"estimateEPS":21.522,"surprise":-8.062000000000001,"surprisePercent":-37.45934392714432}
Earnings
2025-11-07
{"actualRevenue":33020000000,"estimateRevenue":32617000000,"revenueSurprise":403000000,"revenueSurprisePercent":1.235552012754085,"actualEPS":17.83,"estimateEPS":18.5946,"surprise":-0.7646000000000015,"surprisePercent":-4.111946479085335}
Earnings
2025-07-28
{"actualRevenue":31780000000,"estimateRevenue":32199000000,"revenueSurprise":-419000000,"revenueSurprisePercent":-1.301282648529457,"actualEPS":16.19,"estimateEPS":17.5185,"surprise":-1.328499999999998,"surprisePercent":-7.583411821788386}
News
2026-05-22
{"description":"Torrent Pharma said Q4 profit fell 26% as JB Pharma acquisition costs and severance compensation weighed on earnings, highlighting near-term pressure from the deal.","url":"https://www.thehindubusinessline.com/news/torrent-pharma-reports-26-decline-in-net-profit/article71010697.ece","sentiment":"Negative","domain":"The Hindu BusinessLine"}
News
2025-11-10
{"description":"Torrent Pharmaceuticals shares surged 6% to a record high of ₹3,809.15 following strong Q2 earnings, surpassing Cipla in market capitalization rankings. This performance indicates robust investor confidence and growth potential for the company.","url":"https://www.business-standard.com/markets/news/torrent-pharma-soars-6-hits-record-high-surpasses-cipla-in-mcap-ranking-125111000313_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2025-07-01
{"description":"Torrent Pharma's Rs 25,689-crore deal for JB Chem includes an Rs 11,917 crore stake buy from KKR and a Rs 1,639/share open offer, eliciting mixed reactions from analysts regarding the stock's performance.","url":"https://www.zeebiz.com/market-news/news-torrent-pharma-in-focus-stock-holds-steady-as-market-assesses-rs-25689-crore-jb-chemicals-acquisition-371485","sentiment":"Neutral","domain":"Zee Business"}